Panacos Pharmaceuticals, Inc.

PANC · OTC
Analyze with AI
12/31/2007
12/31/2006
12/31/2005
12/31/2004
Operating Activities
Net Income-$37,459-$38,110-$59,078-$12,038
Dep. & Amort.$794$751$629$227
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$868-$44-$348$1,434
Other Non-Cash$4,762$7,773$37,151$604
Operating Cash Flow-$31,035-$29,630-$21,646-$9,773
Investing Activities
PP&E Inv.-$48-$519-$150-$76
Net Acquisitions$0$0$0$0
Inv. Purchases-$235,476-$269,834$0$0
Inv. Sales/Matur.$250,674$244,119$0$0
Other Inv. Act.$0$51$556-$451
Investing Cash Flow$15,150-$26,183$406-$527
Financing Activities
Debt Repay.$19,923$148-$1,160-$185
Stock Issued$1,019$1,698$104,659$14,887
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$332-$31$0$0
Financing Cash Flow$20,610$1,815$103,499$14,702
Forex Effect$0$0$0$0
Net Chg. in Cash$4,725-$53,998$82,259$4,402
Supplemental Information
Beg. Cash$33,140$87,138$4,879$477
End Cash$37,865$33,140$87,138$4,879
Free Cash Flow-$31,083-$30,149-$21,796-$9,849